Multiple myeloma

International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 2003;121:749-57.

https://doi.org/10.1046/j.1365-2141.2003.04355.x

Pardo C, Murillo R, Piñeros M, Castro MA. Casos nuevos de cáncer en el Instituto Nacional de Cancerología E.S.E., Colombia, 2002. Rev Colomb Cancerol 2003;7:4-19.

Greipp PR, San Miguel J, Durie BG, Crowley JJ, Barlogie B, Blade J et al International staging system for multiple myeloma. J Clin Oncol 2005;23:3412-20.

https://doi.org/10.1200/JCO.2005.04.242

Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet JG, Rossi JF et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. N Eng J Med 1996;335:91-7.

https://doi.org/10.1056/NEJM199607113350204

Rajkumar SV, Dispenzieri A, Fonseca R, Lacy MQ, Geyer S, Lust JA et al. Thalidomide for previously untreated indolent or smoldering myeloma. Leukemia 2001;15:1274-6.

https://doi.org/10.1038/sj.leu.2402183

World Health Organization. Classification of tumors of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001. p.142-7.